HBM Bioventures AG Baar ZG Namen - AKT (Switzerland) | 240.0000 |
Date/Time | 04/28 / 20:07 |
Chg. / Chg.(%) | - / |
Bid | - |
Ask | - |
Open | 240.0000 |
Previous Close | 298.9000 |
High | 240.0000 |
Low | 240.0000 |
Volume [USD] | 3,840.0000 |
Volume [Units] | 16 |
Price fixings | 1 |
ISIN | CH0012627250 |
Security | HBMBF |
Exchange | Nasdaq Other OTC |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Lang & Schwa.. | 260.00 | ![]() |
|
SIX Swiss Ex.. | 267.00 | ![]() |
20,397 |
Turquoise | 267.25 | ![]() |
2,167 |
London Domes.. | 269.00 | ![]() |
277 |
Nasdaq Other.. | 240.0000 | 16 | |
Frankfurt | 164.8000 | 50 | |
Berlin | 163.00 | 10 | |
München | 166.00 | 0 | |
Düsseldorf | 164.00 | 0 | |
gettex | 166.000 |
News
- Basilea announces date and agenda of extraordinary general meeting
10/28/2011 / 07:15 - GlobeNewswire - Basilea receives request for extraordinary shareholders meeting to elect additional members to the board of directors
10/06/2011 / 07:16 - GlobeNewswire - Delenex extends its A round to CHF 30.2 million
05/03/2011 / 07:00 - GlobeNewswire - Delenex Therapeutics Secures CHF 13.5 Million Series A Venture Financing
11/12/2010 / 08:00 - GlobeNewswire - MorphoSys Announces Acquisition of Sloning
10/07/2010 / 16:02 - GlobeNewswire